Micafungin indications and usage: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) Created page with "__NOTOC__ {{Micafungin}} {{CMG}}; {{AE}} {{AZ}} ==Indications and Usage== Mycamine® is indicated in adult and pediatric patients 4 months and older for: * '''Candidemia'''..." |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 9: | Line 9: | ||
* '''Candidemia''' | * '''Candidemia''' | ||
*'''Acute Disseminated Candidiasis''' *'''Candida Peritonitis''' and '''Abscesses''' | *'''Acute Disseminated Candidiasis''' | ||
*'''Candida Peritonitis''' and '''Abscesses''' | |||
*'''Esophageal Candidiasis''' | |||
Mycamine has '''not been''' adequately studied in patients with [[endocarditis]], [[osteomyelitis]] and [[meningitis]] due to [[Candida]] infections. | Mycamine has '''not been''' adequately studied in patients with [[endocarditis]], [[osteomyelitis]] and [[meningitis]] due to [[Candida]] infections. | ||
*'''Prophylaxis of Candida Infections in Patients Undergoing Hematopoietic Stem Cell Transplantation''' | |||
Prophylaxis of Candida Infections in Patients Undergoing Hematopoietic Stem Cell Transplantation | |||
'''NOTE:''' The efficacy of Mycamine against infections caused by fungi other than Candida has not been established.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MYCAMINE (MICAFUNGIN SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ASTELLAS PHARMA US, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a064c4a7-25ec-4a2c-afc2-703491a4a38b#nlm34090-1 | publisher = | date = | accessdate = }}</ref> | '''NOTE:''' The efficacy of Mycamine against infections caused by fungi other than Candida has not been established.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MYCAMINE (MICAFUNGIN SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ASTELLAS PHARMA US, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a064c4a7-25ec-4a2c-afc2-703491a4a38b#nlm34090-1 | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 10:36, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Indications and Usage
Mycamine® is indicated in adult and pediatric patients 4 months and older for:
- Candidemia
- Acute Disseminated Candidiasis
- Candida Peritonitis and Abscesses
- Esophageal Candidiasis
Mycamine has not been adequately studied in patients with endocarditis, osteomyelitis and meningitis due to Candida infections.
- Prophylaxis of Candida Infections in Patients Undergoing Hematopoietic Stem Cell Transplantation
NOTE: The efficacy of Mycamine against infections caused by fungi other than Candida has not been established.[1]
References
Adapted from the FDA Package Insert.